Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development
Go back to Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development| (NASDAQ: ELVN) | Delayed: 54.81 +0.86 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.95 | 52 Week High | $ | |||
| Open | $54.10 | 52 Week Low | $ | |||
| Day High | $55.82 | P/E | N/A | |||
| Day Low | $53.10 | EPS | $ | |||
| Volume | 660,426 | |||||
